GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Tecogen Inc (OTCPK:TGEN) » Definitions » Operating Income

Tecogen (Tecogen) Operating Income : $-4.06 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tecogen Operating Income?

Tecogen's Operating Income for the three months ended in Mar. 2024 was $-1.06 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $-4.06 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Tecogen's Operating Income for the three months ended in Mar. 2024 was $-1.06 Mil. Tecogen's Revenue for the three months ended in Mar. 2024 was $6.19 Mil. Therefore, Tecogen's Operating Margin % for the quarter that ended in Mar. 2024 was -17.09%.

Tecogen's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Tecogen's annualized ROC % for the quarter that ended in Mar. 2024 was -21.75%. Tecogen's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -41.67%.


Tecogen Operating Income Historical Data

The historical data trend for Tecogen's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecogen Operating Income Chart

Tecogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.05 -2.84 0.05 -2.39 -4.45

Tecogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.45 -0.80 -0.37 -1.83 -1.06

Tecogen Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tecogen  (OTCPK:TGEN) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Tecogen's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-4.228 * ( 1 - -2.06% )/( (19.423 + 20.252)/ 2 )
=-4.3150968/19.8375
=-21.75 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Tecogen's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-4.188/( ( (2.106 + max(7.961, 0)) + (3.323 + max(6.713, 0)) )/ 2 )
=-4.188/( ( 10.067 + 10.036 )/ 2 )
=-4.188/10.0515
=-41.67 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.735 + 10.553 + 0.361) - (7.019 + 1.823 + 0.846)
=7.961

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.533 + 10.021 + 0.41) - (6.697 + 2.625 + 0.929)
=6.713

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Tecogen's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-1.057/6.186
=-17.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Tecogen Operating Income Related Terms

Thank you for viewing the detailed overview of Tecogen's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecogen (Tecogen) Business Description

Traded in Other Exchanges
Address
45 First Avenue, Waltham, MA, USA, 02451
Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production. Products segment designs, manufactures and sells industrial and commercial cogeneration systems. Services segment provides operations and maintenance services and turn-key installation for products under long term service contracts. Energy Production segment sells energy in the form of electricity, heat, hot water and cooling to the customers under long-term energy sales agreements.
Executives
Earl R Lewis director C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
John Hatsopoulos director, 10 percent owner, officer: Chief Executive Officer 85 FIRST AVENUE, WALTHAM MA 02451
Susan B Hirsch director 280 OLD SOMERSET ROAD, WATCHUNG NJ 07069
Abinand Rangesh director, officer: Chief Financial Officer 45 FIRST AVE, WALTHAM MA 02451
John M Albertine director 100 FEDERAL DRIVE, FREDERICKSBURG VA 22405
Pacheco Ann Marie Brown 10 percent owner, other: Trustee C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
Ralph Jenkins director 45 FIRST AVE, WALTHAM MA 02451
Fred Holubow director
Locke M. Benjamin officer: Co-CEO 45 FIRST AVE, WALTHAM MA 02451
Whiting John Kimball Iv officer: General Counsel & Secretary 49 L STREET, UNIT 9, BOSTON MA 02127
Deanna M Petersen director 45 FIRST AVENUE, WALTHAM MA 02451
Yiannis Monovoukas 10 percent owner TEI BIOSCIENCES, INC., 7 ELKINS STREET, BOSTON MA 02127
Charlest Maxwell director 6100 NORTH WESTERN AVE, OKLAHOMA CITY OK 73118
Keith Davidson director C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
David A Garrison officer: CFO, Treasurer and Secretary C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420

Tecogen (Tecogen) Headlines